The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology ...

Eleonora Teplinsky, MD, a medical oncologist specializing in breast and gynecologic cancers, has seen unregulated and ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

BioAtla Inc (BCAB) reports promising clinical progress and strategic initiatives, despite facing financial constraints and operational challenges.

ImmunoPrecise Antibodies Ltd. ( NASDAQ: IPA) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - Interim Chief ...

Philip Taylor; Investor Relations; Pulse Biosciences Inc. Paul Laviolette; Co-Chairman of the Board, President, Chief Executive Officer; Pulse Biosciences Inc. Jon S ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

The Kentucky Attorney General’s Office on Thursday announced more than $19.8 million was awarded to 75 Kentucky organizations ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

Q4 2024 Management View CEO Raymond Tesi highlighted the transformative potential of 2024 for INmune Bio, emphasizing upcoming milestones. He noted the Phase 2 trial of XPro for Alzheimer's disease, ...

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the ...